Riskpilot← Back to searchSign inGet full accessAROS PHARMA ApS
APSIn liquidationCVR 32102816Ole Maaløes Vej 3Manufacture of pharmaceutical preparations · NACE 2120Est. 20091 employees
Revenue 2015
—
EBITDA margin
—
+70% vs 2014
Equity ratio
-220.7%
Financial strength
Net profit 2015
DKK -722K
+75% vs 2014
| Revenue | — | — |
| EBITDA | DKK -723K | +70% |
| Net profit | DKK -722K | +75% |
| Total assets | DKK 1,5M | -31% |
| Equity | DKK -3,4M | -27% |
| Employees | 1 | — |
Legal name
AROS PHARMA ApS
CVR number
32102816
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
2. april 2009
Share capital
DKK 367.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2015-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Address
Ole Maaløes Vej 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Staff expenses | -0 | -619 | -580 | -393 |
| EBITDA | -4.304 | -4.762 | -2.397 | -723 |
| Depreciation & amort. | -0 | -0 | -0 | -0 |
| EBIT | -4.304 | -4.762 | -2.397 | -723 |
| Net financials | 56 | -268 | -508 | 1 |
| Profit before tax | -4.248 | -5.029 | -3.649 | -722 |
| Tax | -1.002 | -1.128 | -0 | -0 |
| Net profit | -3.246 | -3.901 | -2.904 | -722 |
| Item | 2012 | 2013 | 2014 | 2015 |
|---|---|---|---|---|
| Total assets | 4.719 | 4.622 | 2.218 | 1.527 |
| Equity | 4.156 | 255 | -2.649 | -3.371 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 562 | 4.367 | 4.867 | 4.898 |
| Total debt | 562 | 4.367 | 4.867 | 4.898 |
EBITDA margin
-72302200.0%
This company
15.8%
Market median
-457608961% vs market
20122015
Equity ratio
-220.7%
This company
38.2%
Market median
-678% vs market
20122015
Return on equity
-72183700.0%
This company
18.4%
Market median
-392302817% vs market
20122015
Net profit margin
-72183700.0%
This company
8.1%
Market median
-891156890% vs market
20122015
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20122015
Debt / equity
1.45×
This company
0.62×
Market median
-134% vs market
20122015
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MB Management | Management | 2009 | — | — |
MP Unofficial title | Unofficial title | 2015 | — | — |
HB Chief Executive Officer | Chief Executive Officer | 2010 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2009 | — | — | |
| Board of Directors | 2009 | — | — | |
| Chairman | 2009 | — | — | |
| Board of Directors | 2011 | — | — | |
| Board of Directors | 2013 | — | — | |
| Chairman | 2009 | — | — | |
| Board of Directors | 2010 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Novo Holdings A/S | Company | 50.0% | 50.0% | 2011 |
PreSeed Ventures A/S | Company | 25.0% | 25.0% | 2011 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AROS PHARMA ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Martin Bonde | Management | 0 companies |
| Marianne Philip | Unofficial title | 0 companies |
| Henrik Blou | Chief Executive Officer | 0 companies |
| Bobby G Soni | Board of Directors | 0 companies |
| Kim Lennart Dueholm | Board of Directors | 0 companies |
| Stephan Christgau | Chairman | 0 companies |
| Ole Bitsch-Jensen | Board of Directors | 0 companies |
| Line Holten Reimer | Board of Directors | 0 companies |
| Peter Finsel Bisgaard | Chairman | 0 companies |
| Mads Buhl Axelsen | Board of Directors | 0 companies |